- Report
- December 2024
- 85 Pages
Spain
From €3185EUR$3,500USD£2,731GBP
- Report
- September 2024
- 80 Pages
France
From €3185EUR$3,500USD£2,731GBP
- Report
- January 2021
Global
From €4095EUR$4,500USD£3,511GBP
Novolin N is a brand of human insulin used to treat diabetes mellitus, a metabolic disorder. It is a short-acting insulin that is used to control high blood sugar levels in people with type 1 and type 2 diabetes. Novolin N is a clear, colorless solution that is injected subcutaneously. It is used in combination with other diabetes medications to help control blood sugar levels. Novolin N is available in vials, cartridges, and pens. It is also available in combination with other diabetes medications, such as NovoLog and NovoRapid.
Novolin N is part of the Endocrine and Metabolic Disorders Drugs market, which includes medications used to treat a variety of endocrine and metabolic disorders, such as diabetes, thyroid disorders, and obesity. These medications are used to control blood sugar levels, regulate hormones, and reduce the risk of complications associated with metabolic disorders.
Companies in the Novolin N market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Pfizer. Show Less Read more